C07C 237/18
The carbon skeleton being unsaturated and containing rings other than six-membered aromatic
Official title: the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
C07C237/18 (The carbon skeleton being unsaturated and containing rings other than six-membered aromatic) appears on 11 US grants and 12 published applications in this corpus.
Search patents in C07C- Granted patents
- 11
- Published applications
- 12
- Assignees
- 7
- Inventors
- 43
- Latest grant
- 21 Dec 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 1 | 1 |
| 2004 | 1 | 0 |
| 2005 | 0 | 1 |
| 2006 | 1 | 2 |
| 2007 | 1 | 0 |
| 2008 | 0 | 2 |
| 2009 | 3 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 2 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
By publication year.
Recent patents
- Analogs of 3-amino-4-(propan-2-ylidene)cyclopentane-1-carboxylic acid and uses thereof for treating diseases and disorders associated with ornithine aminotransferase activity21 Dec 2021US 11,203,596 B2Northwestern University
- Heterocyclic inhibitors of the sodium channel19 Feb 2019US 10,208,023 B2
- Esteramines and derivatives from natural oil metathesis24 Oct 2017US 9,796,662 B2Stepan Company
- Esteramines and derivatives from natural oil metathesis17 Nov 2015US 9,187,711 B2Stepan Company
- Geranyl compounds25 Aug 2009US 7,579,376 B2Ohgen Research Laboratories, Ltd.
- Analogs of 3-amino-4-(propan-2-ylidene)cyclopentane-1-carboxylic acid and uses thereof for treating diseases and disorders associated with ornithine aminotransferase activity24 Sep 2020US 2020/0299296 A1Northwestern University
- Esteramines and derivatives from natural oil metathesis28 Jan 2016US 2016/0023989 A1Stepan Company
- Heterocyclic inhibitors of the sodium channel21 Jan 2016US 2016/0016939 A1Zalicus Pharmaceuticals Ltd.
- Esteramines and derivatives from natural oil metathesis29 Aug 2013US 2013/0225859 A1Stepan Company
- 2- acetamide10 May 2012US 2012/0111098 A1Medichem, S.A.
Most cited
By later US patents
- Lymphocyte function antigen-1 antagonists15US 6,630,492 B1Novartis AG · 2003
- Melvinolin derivatives5US 6,818,638 B2Novartis AG · 2004
- Esteramines and derivatives from natural oil metathesis4US 9,187,711 B2Stepan Company · 2015
- Geranyl compounds3US 7,125,852 B2Ohgen Research Laboratories, Ltd. · 2006
- Dimer poly-quaternary compounds2US 7,193,111 B1Surfa Tech Corporation · 2007